VIROBLOCK SA specialises in the discovery and development of a brand new generation of antiviral products with a novel mechanism of action against enveloped viruses, which include major human pathogens such as human and avian influenzas, SARS virus and the AIDS virus.
Member count: 1-10
Total raised: $836.681K
Founded date: 2006
Investors 2
| Date | Name | Website |
| - | BlueOcean ... | blueocean-... |
| - | Fongit See... | fongitseed... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 28.02.2012 | Series C | $836.681K | - | finsmes.co... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 26.06.2013 | Viroblock ... | Viroblock SA, a Swiss start-... | - | - | startuptic... |
| 04.01.2013 | Viroblock ... | Airborne Pathogens are a maj... | - | - | startuptic... |
| 28.02.2012 | Viroblock ... | Viroblock S.A., a Switzerland-... | funding S... | - | finsmes.co... |
| 28.10.2011 | Viroblock ... | Viroblock S.A. is a Swiss-ba... | - | - | startuptic... |
| 02.12.2010 | CTI Start-... | 5 companies were presenting ... | - | - | startuptic... |